
Everyone collects weak signals now. Most of what they collect predicts nothing. A weak signal isn't a thing you spot, it's a prediction you make, and the edge goes to whoever bets on it while being wrong is still cheap.
So how do you become the one placing the bet, not the one still collecting reports? Let's get into it.
What a Weak Signal Actually IsA weak signal is a faint piece of evidence that points to something a customer will want before they can name it, and before the market has priced it in. Faint, because if it were loud, everyone would already be acting on it. Deniable, because you can always explain it away as noise, and most people do. That deniability is the whole point. The moment it becomes undeniable, the advantage is gone and the price has moved.
Why Noticing Stopped Being the EdgeTen years ago, noticing was hard. You needed sources, a network, time to read widely, a feel for the edges of your industry. That was the moat. It isn't anymore. Every team has a trend report and three newsletters and an AI tool surfacing emerging behaviors on a schedule. The noticing got automated. What didn't get automated is the judgment about which signal predicts a structural change and which points to nothing real, and the nerve to act early.
Inside Roche's Innovation BoardI sat on Roche's diagnostics innovation board, the only outsider in the room, helping decide which ideas got funded. At one point we took on diabetes care.
I am not diabetic. So I had Roche ship me every meter and test strip they made, and I pricked my finger up to a dozen times a day to feel what their customers felt. You cannot innovate for a customer whose day you have never lived. Skip that, and everything after is a guess.
Roche was a leader in blood glucose testing with its Accu-Chek meters, and the math looked obvious. Someone with type 1 diabetes tests around eight times a day, every day, for life. A big, stable business. Type 2 was the smaller story per patient. Those patients tested once, maybe twice a day, so each one looked worth less, and we filed the category under "less interesting." We could already see type 2 climbing. We weighed it against the per-patient math and explained it away.
Then type 2 diagnoses exploded into one of the fastest-growing chronic conditions in the world. And the category stopped being about counting tests per day at all, because monitoring went continuous, the always-on sensors people wear today. We had seen the early edge of both shifts. We even predicted them. We just didn't move fast enough, and the reason is the one that kills most weak signals inside a big company. Project approval and annual budgets are built to fund what's already proven, not to chase something still faint.
Roche got there. Accu-Chek SmartGuide, its real-time continuous monitor, is on the market now. I just wish we had moved the moment we saw it, instead of waiting for the next budget cycle to make it safe.
How to Read a Weak SignalWe didn't miss the type 2 signal for lack of noticing. We noticed. We missed it on the three things that come after, and those you can train. The moves start once you've got a signal you can't quite dismiss, and the skill is what you do with it.
A canary in a coal mine matters because the air changed. It signals something structural, a shift in the environment that affects everyone in it, whether they've noticed yet or not. A costume is the opposite. A few people put it on, it's striking, it spreads for a season, then they take it off and the room is exactly as it was. On day one the two look identical. A behavior appears, it's unusual, it's spreading. The only question that matters is whether it predicts a change a customer can't reverse, or a moment that will pass.
Back in 2018 I wr